ArticleDigestive diseases and sciences2026
Genetic Analysis of Isolated Hepatic Ductal Plate Malformation Reveals Novel Variants and Insights into Phenotypic Correlation.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolycystic liver disease and other manifestations of ductal plate malformation (DPM) may be incidental or indeed develop significant complications. The genetic basis of 'isolated' DPM differs from that associated with polycystic kidney disease and remains incompletely understood.
aimsWe sought to genetically characterize a sizeable single-center cohort of patients with 'isolated' DPM, defined as absence of polycystic kidney disease.
methods55 consecutive patients with isolated DPM were analyzed retrospectively with next-generation sequencing used to identify genetic variants.
results54/55 completed genetic characterization. 40 patients had polycystic liver disease (PCLD) as the primary phenotype, 9 had congenital hepatic fibrosis (CHF), 1 had Caroli disease and 5 had multiple biliary hamartomas. 10 patients had mixed phenotype. The majority were female (78%) and mean age at presentation was 47 years. Of patients with PCLD, previous estrogen exposure was associated with cyst complications. Of the 54 genetically analyzed patients, pathogenic or likely pathogenic variants were identified in 31. PCLD was mainly associated with SEC63, PRKCSH and GANAB heterozygous variants with a minor contribution from PKHD1 and ALG8. PRKCSH followed by GANAB was associated with the most severe PCLD presentation. CHF was represented solely by PKHD1 variants half of which were missense, as opposed to truncating in all but one of the other genotypes. Importantly, 5 novel variants were identified (4 SEC63, 1 PRKCSH).
conclusionsWe have shown that current genetic testing methods are often revealing in isolated DPM. Future broadening of genetic analysis will enhance diagnosis and understanding within this heterogeneous disease spectrum.
Indexed as
Identifiers
42365546What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.